0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters   |    
Overstating the Case About Recovery?
Peter C. Brown; William M. Tucker, M.D.
Psychiatric Services 2005; doi: 10.1176/appi.ps.56.8.1022-a

In Reply: We thank Drs. Remington and Shammi for their thoughtful comments and for giving us the opportunity to clarify the inspiration for—and the intent of—our recommendations. We agree wholeheartedly with them and with the authors whose work they cite that the second-generation antipsychotics, other than clozapine, offer only modest improvements, at best, over their predecessors. Rather, the expectation of a more favorable outcome for many patients with schizophrenia derives from the observations of Harding and Brooks (1) and from Strauss and Carpenter (2), among others, who studied the longitudinal course of patients treated with first-generation antipsychotics beginning nearly half a century ago.

Indeed, the expectation of a pharmacologic magic bullet to cure schizophrenia may contribute to the reluctance of our professional peers to actively pursue the outcomes that were reported possible in these earlier studies. Such reluctance has been well highlighted in findings of the small number of treatment programs that meet the Schizophrenia Patient Outcomes Research Team standards, which were widely accepted in theory but only rarely in practice (3).

Such outcomes are enhanced by applying the best overall treatment methods currently available (4). These approaches require considerably more than pharmacologic interventions and thus will require both program restructuring and more effective use of resources. Motivation to improve will grow as differences emerge between outcomes of treatment programs that are competing for ever-scarcer funds. Programs will ultimately be evaluated by payers on the basis of successful outcomes. Dramatic differences in outcomes are already emerging in the general health arena (5), and in our field they cannot be far behind.

Harding CM, Brooks GW, Ashikaga T, et al: The Vermont longitudinal study: II. long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 144:727—735,  1987
[PubMed]
 
Strauss JS, Carpenter WT: Characteristic symptoms and outcome in schizophrenia. Archives of General Psychiatry 30:429—434,  1974
[PubMed]
 
Lehman A, Steinwachs DM: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophrenia Bulletin 24:11—20,  1998
[PubMed]
 
Drake RE, Goldman HH, Leff HS, et al: Implementing evidence-based practices in routine mental health service settings. Psychiatric Services 52:179—182,  2001
[PubMed]
[CrossRef]
 
Gawande A: The bell curve. New Yorker, Dec 6, 2004, pp 82—91
 
+

References

Harding CM, Brooks GW, Ashikaga T, et al: The Vermont longitudinal study: II. long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 144:727—735,  1987
[PubMed]
 
Strauss JS, Carpenter WT: Characteristic symptoms and outcome in schizophrenia. Archives of General Psychiatry 30:429—434,  1974
[PubMed]
 
Lehman A, Steinwachs DM: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophrenia Bulletin 24:11—20,  1998
[PubMed]
 
Drake RE, Goldman HH, Leff HS, et al: Implementing evidence-based practices in routine mental health service settings. Psychiatric Services 52:179—182,  2001
[PubMed]
[CrossRef]
 
Gawande A: The bell curve. New Yorker, Dec 6, 2004, pp 82—91
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 38.  >
APA Practice Guidelines > Chapter 4.  >
APA Practice Guidelines > Chapter 4.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 20.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles